The largest database of trusted experimental protocols

Etest methodology

Manufactured by bioMérieux
Sourced in France, Sweden

The Etest methodology is a stable, quantitative, and user-friendly antimicrobial susceptibility testing (AST) technique developed by bioMérieux. The Etest provides minimum inhibitory concentration (MIC) values, which are essential for determining the appropriate antimicrobial treatment for patients.

Automatically generated - may contain errors

7 protocols using etest methodology

1

Antibiotic Resistance Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Resistance to β-lactam antibiotics (benzylpenicillin, oxacillin, cefoxitin and ceftaroline) was determined using Etest methodology (bioMérieux). MSSA ATCC 25923 was used as a control. Results were interpreted according to EUCAST clinical breakpoints.
+ Open protocol
+ Expand
2

Comprehensive Bacterial Identification and Antimicrobial Resistance Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Species identification was performed using the Microscan WalkAway 40 S1 identification system (Dade Behring, Deerfield, IL, USA). The 16s rDNA and rpoB gene sequences were also analyzed to confirm the species identity. Susceptibility of the isolates to antibiotic was determined by the E-test methodology (BioMerieux SA, La Balme-les-Grottes, France). Modified Hodge test was performed to screen for carbapenemases. The results were interpreted according to the 2011 Clinical and Laboratory Standards Institute recommendation [19] . The relationship of NDM-1 positive and negative E. coli strains isolated from the same fecal samples was analyzed by PFGE (Pulsed Field Gel Electrophoresis)-Xba I digestion method, following the protocol previously described [20] (link).
+ Open protocol
+ Expand
3

Antimicrobial Susceptibility of Clinical E. coli and K. pneumoniae

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical samples were collected from the Al-Makassed Hospital in Lebanon and were stored as part of routine clinical care 16S rRNA gene sequencing and BLAST were used to identify the isolates [14 (link)]. The disk diffusion on Mueller-Hinton agar was used to determine the susceptibility profiles of the isolates against aztreonam, norfloxacin, tobramycin, sulfamethoxazole/trimethoprim, amikacin, gentamicin, tetracycline, and ciprofloxacin. Susceptibility to ertapenem, imipenem, and meropenem was determined by the E-test methodology (BioMérieux, France). Results were interpreted according to the CLSI guidelines (CLSI, 2023) [15 ]. Isolates undertaken in this study were three E. coli (designated as EC20, 21, and 22; Accession Numbers: NZ_JAAJRZ000000000.1 (EC20), NZ_JAAJSD000000000.1 (EC21), NZ_JAAJRY000000000.1 (EC22) and one K. pneumoniae (Accession Number: JBBJJS000000000.1).
+ Open protocol
+ Expand
4

Characterisation of Meningococcal Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Laboratories refer all confirmed meningococcal samples to the Irish Meningococcal and Meningitis Reference Laboratory (IMMRL) for further characterisation. Specimens from all eight cases reported here were processed in the IMMRL by polymerase chain reaction (PCR) testing [11, (link)12] (link). Characterisation of N. meningitidis isolates using multilocus sequence typing (MLST) [13] (link), porA [14] (link) and fetA [15] (link) variable region finetyping was also undertaken at the Epidemiology and Molecular Biology Unit (EMBU), which is linked to the IMMRL.
Antimicrobial susceptibility testing to cefotaxime, ciprofloxacin, penicillin, rifampicin and sulfadiazine was performed using Etest methodology according to the manufacturer's instructions (BioMérieux).
+ Open protocol
+ Expand
5

Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility testing was performed by the disk diffusion technique on Mueller-Hinton agar and it included a panel of 26 antibiotic disks belonging to 15 classes (Supplementary Table S1). Additionally, carbapenems were tested by the E-test methodology (AB BIODISK, Solna, Sweden) to determine the minimal inhibitory concentrations (MICs) of ertapenem, imipenem, and meropenem. The obtained data was interpreted according to the CLSI guidelines (CLSI, 2017) and Galani et al.14 (link).
+ Open protocol
+ Expand
6

Antimicrobial Susceptibility of S.pneumoniae

Check if the same lab product or an alternative is used in the 5 most similar protocols
The minimal inhibiting concentrations (MICs) of antimicrobial agents, including erythromycin, penicillinG, co-trimoxazole, vancomycin, cefotaxime, ceftriaxone clindamycin, tetracycline, amoxicillin, chloromycetin and levofloxacin were measured using the E-test methodology (AB BioDisk, Switzerland). S.pneumoniae ATCC49619 was used as a quality control strain in antimicrobial susceptibility tests. The interpretations of MIC breakpoints and test results were made according to the recommended method of the Clinical and Laboratory Standards Institute (CLSI)criteria [20] . Isolates not susceptible to at least three antibiotic families were defined as multidrug-resistant (MDR) S.pneumoniae.
+ Open protocol
+ Expand
7

Toxigenicity and Antimicrobial Susceptibility of C. difficile

Check if the same lab product or an alternative is used in the 5 most similar protocols
Toxin production of the isolates was tested using an immunochromatographic method, detecting toxin A and toxin B (C. difficile QuikChek Complete, Techlab, Blacksburg, VA, USA). Samples with a GDH-positive, but toxin A/B negative results were further tested with the TC (toxigenic culture) method [44 (link)]. Strain typing was performed by PCR ribotyping method as described by Stubbs et al. [53 (link)].
Metronidazole (MET), vancomycin (VAN), clindamycin (CLI) and rifampicin (RIF) susceptibility of the isolates were tested using the E-test methodology (AB BIODISK, Solna, Sweden). A Cd suspension (of 0.5 McFarland turbidity) of each strain was swabbed on Brucella agar (Oxoid, UK) supplemented with 5% defibrinated sheep blood, 1 mg/L hemin and 5 mg/L Vitamin K1 [50 (link)]. E-test strips of MET, VAN, CLI and RIF were applied onto the agar surface and the plates were incubated in an anaerobic atmosphere for 24–48 h. MICs were read at the point at which the zone of complete inhibition intersected the MIC scale. For the evaluation of the susceptibility of the tested isolates, EUCAST breakpoints and epidemiological cut-off values (in case of RIF) were used (http://www.eucast.org). C. difficile ATCC 9689, C. perfringens ATCC 13,124, B. fragilis ATCC 25,285 and C. acnes ATCC 11,827 were used as control strains.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!